Skip to main content

Korro Bio, Inc.

KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001703647

In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Korro Bio, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of KRRO: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7571−4
Shares9.70M9.05M−653.4K (−6.7%)
Value$169.0M$114.8M−$54.2M (−32.1%)

New holders (11)

Institutions that held Korro Bio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to KRRO in Q2 2025
InstitutionSharesValue% of portfolio
Blue Owl Capital Holdings LP125,000$1.56M0.50%
Renaissance Technologies LLC45,700$570.8K0.00%
Two Sigma Investments, LP36,746$459.0K0.00%
D. E. Shaw & Co., Inc.24,383$304.5K0.00%
Trexquant Investment LP20,870$260.7K0.00%
Versant Capital Management, Inc282$3.52K0.00%
Rise Advisors, LLC29$3620.00%
EverSource Wealth Advisors, LLC22$2750.00%
IFP Advisors, Inc0$750.00%
Essential Partners LLC3$370.00%
Northwestern Mutual Wealth Management Co2$250.00%

Sold out (15)

Institutions that held Korro Bio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of KRRO in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Alliancebernstein L.P.680,517$11.8M
Franklin Resources Inc91,704$1.60M
Schonfeld Strategic Advisors LLC30,475$530.6K
Goldman Sachs Group Inc20,944$364.6K
Blair William & Co16,230$282.6K
Nuveen, LLC12,145$211.4K
XTX Topco Ltd10,600$184.5K
Susquehanna International Group, LLP10,372$180.6K
Barclays PLC7,241$126.1K
MetLife Investment Management3,639$63.4K
Corebridge Financial, Inc.3,019$52.6K
Federated Hermes, Inc.64$1.11K
BNP Paribas59$1.03K
Spire Wealth Management39$679
True Wealth Design, LLC1$18